Zobrazeno 1 - 10
of 46
pro vyhledávání: '"LADISLAV JEBAVY"'
Publikováno v:
Biomedical Papers, Vol 161, Iss 1, Pp 92-99 (2017)
Background and Aims: Despite high-dose multi-agent chemotherapy and allogeneic stem cell transplantation, the relapse rate of acute myeloid leukemia (AML) is high. Further, the disease is highly resistent to drugs. We speculated that deeper understan
Externí odkaz:
https://doaj.org/article/281f3e2cafa84d5fbe5abe820a15faf7
Autor:
Tomas Kupsa, Jan Vanek, Martina Vasatova, Iva Karesova, Pavel Zak, Ladislav Jebavy, Jan M. Horacek
Publikováno v:
Biomedical Papers, Vol 160, Iss 1, Pp 94-99 (2016)
Objectives: Acute myeloid leukemia (AML) cells are highly resistant to therapy. The presumed molecular basis of this resistance is the effect of tumor necrosis factor alpha (TNF-α) and other cytokines on endothelial adhesion molecule expression. The
Externí odkaz:
https://doaj.org/article/1e90adf83dfc4d23839fb14f8c782f59
Publikováno v:
Biomedical Papers, Vol 159, Iss 1, Pp 001-011 (2015)
Background: The treatment of malignancies like acute myeloid leukemia (AML) is often complicated by the heterogeneity of the disease and the mechanisms of the disease progression. This heterogeneity is often not reflected in standard treatment approa
Externí odkaz:
https://doaj.org/article/cf0602a4260848c89946a56d9806a91e
Publikováno v:
Biomedical Papers, Vol 159, Iss 2, Pp 299-301 (2015)
Aims: To compare serum levels of 17 cytokines and 5 adhesion molecules in patients with newly diagnosed acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL) using biochip array technology. Methods: A total of 15 AML and 15 ALL patients
Externí odkaz:
https://doaj.org/article/6dc85481f5754c02a9bc218b1968572e
Publikováno v:
São Paulo Medical Journal, Vol 125, Iss 6, Pp 359-361
CONTEXT AND OBJECTIVE: This study evaluated the effect of selected psychosocial, health and demographic characteristics of quality of life (QOL) among patients treated with autologous hematopoietic stem cell transplantation (HSCT). DESIGN AND SETTING
Externí odkaz:
https://doaj.org/article/811629854dfc4205ad8aadc327df9233
Autor:
SHARON ELAD, RENATE SCHMELZ, EVA WAGNER, ALBERTO BOSI, JANA BABATZ, RALF MEYER, IRENE DONNINI, MICHAEL SHAPIRA, DOMINIK HEIM, JÖRG HALTER, MICHAEL KOLDEHOFF, KERSTIN SCHÄFER-ECKARDT, HILDEGARD GREINIX, GUISEPPE IRRERA, GÜLSAN SUCAK, HEDWIG KASPARU, GUIDO KOBBE, ULRICH DUENZINGER, LADISLAV JEBAVY, TIMOTHY MEILLER, JOEL EPSTEIN, YEHUDA ZADIK, RALF MOHRBACHER, ROLAND GREINWALD, DANIEL WOLFF
Publikováno v:
Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology. 135:e42-e43
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e802438a2bbc12e8b010ea8512fbfd10
https://doi.org/10.1016/j.oooo.2022.09.028
https://doi.org/10.1016/j.oooo.2022.09.028
Autor:
SHARON ELAD, RENATE SCHMELZ, EVA WAGNER, ALBERTO BOSI, JANA BABATZ, RALF MEYER, IRENE DONNINI, DOMINIK HEIM, JÖRG HALTER, DANIEL WOLF WOLFF, MICHAEL KOLDEHOFF, KERSTIN SCHÄFER-ECKARDT, HILDEGARD GREINIX, GUISEPPE IRRERA, GÜLSAN SUCAK, HEDWIG KASPARU, GUIDO KOBBE, ULRICH DUENZINGER, LADISLAV JEBAVY, TIMOTHY MEILLER, JOEL EPSTEIN, YEHUDA ZADIK, RALF MOHRBACHER, ROLAND GREINWALD, MICHAEL SHAPIRA
Publikováno v:
Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology. 135:e43-e44
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3512002eba18cffe54b1524f30d3c3a4
https://doi.org/10.1016/j.oooo.2022.09.029
https://doi.org/10.1016/j.oooo.2022.09.029
Publikováno v:
Experimental Oncology.
AIM To evaluate serum levels of selected cytokine receptors in B-cell precursor acute lymphoblastic leukemia (B-ALL) and their association with acknowledged prognostic factors, relapse-free survival (RFS) and overall survival (OS). MATERIALS AND METH
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c8b069ed7e9c2ad67b5044533e88f75c
https://doi.org/10.32471/exp-oncology.2312-8852.vol-43-no-3.16548
https://doi.org/10.32471/exp-oncology.2312-8852.vol-43-no-3.16548
Publikováno v:
Cytokine. 128
Background Acute myeloid leukemia (AML) cells are highly resistant to chemotherapeutic drugs. Cytokines and adhesion molecules may contribute to this resistance and affect treatment outcome. The aim of this study was to evaluate the independence and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7a362cf3de8bb21cb77c3c16c10e8c18
https://pubmed.ncbi.nlm.nih.gov/32006876
https://pubmed.ncbi.nlm.nih.gov/32006876
Publikováno v:
Biomedical Papers, Vol 159, Iss 1, Pp 001-011 (2015)
Background. The treatment of malignancies like acute myeloid leukemia (AML) is often complicated by the heterogeneity of the disease and the mechanisms of the disease progression. This heterogeneity is often not reflected in standard treatment approa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d9ad5140d12f6c09c115a8f0df5bc623
https://biomed.papers.upol.cz/artkey/bio-201501-0001_The_role_of_adhesion_molecules_in_acute_myeloid_leukemia_and_hemato_oncology_A_systematic_review.php
https://biomed.papers.upol.cz/artkey/bio-201501-0001_The_role_of_adhesion_molecules_in_acute_myeloid_leukemia_and_hemato_oncology_A_systematic_review.php